Medicure (MCUJF) Total Non-Current Liabilities (2011 - 2026)
Medicure (MCUJF) posted quarterly Total Non-Current Liabilities of $253763.6 for Q1 2026, down 18.36% year-over-year from $310824.7 in Q1 2025, and down 17.12% quarter-over-quarter from $306195.8 in Q4 2025.
Medicure (MCUJF) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Medicure's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $253763.6 for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 18.36% year-over-year to $253763.6; the TTM figure through Mar 2026 stood at $253763.6 (down 18.36% YoY), while the FY2025 annual figure was $305613.1, down 17.31% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $253763.6, down from $306195.8 in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $1.1 million in Q1 2022, with the low at $136723.3 in Q2 2024.
- The 5-year median for Total Non-Current Liabilities is $339035.0 (2024), against an average of $433540.6.
- The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities slumped 79.85% in 2023, then jumped 222.52% in 2025.
- Medicure's Total Non-Current Liabilities stood at $370561.6 in 2022, then tumbled by 54.61% to $168208.6 in 2023, then soared by 115.34% to $362219.7 in 2024, then decreased by 15.47% to $306195.8 in 2025, then fell by 17.12% to $253763.6 in 2026.
- Business Quant data shows MCUJF's Total Non-Current Liabilities at $253763.6 in Q1 2026, $306195.8 in Q4 2025, and $377850.2 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.27 Bn | 43.31 Bn | - | -13.28 Bn |
| 2 | Teva Pharmaceutical Industries | 43.64 Bn | 39.99 Bn | 2.15 Bn | 16.45 Bn |
| 3 | Zoetis | 32.26 Bn | 30.58 Bn | 1.05 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 33.50 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.62 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.86 Bn | 17.98 Bn | 1.46 Bn | 18.76 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.37 Bn |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | 6.42 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 334.00 Mn |
| 10 | Medicure | 96.01 Mn | 94.89 Mn | 2.57 Mn | 253,763.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253,763.58 |
| Dec 31, 2025 | 306,195.84 |
| Sep 30, 2025 | 377,850.20 |
| Jun 30, 2025 | 440,966.34 |
| Mar 31, 2025 | 310,824.75 |
| Dec 31, 2024 | 362,219.67 |
| Sep 30, 2024 | 407,577.70 |
| Jun 30, 2024 | 136,723.28 |
| Mar 31, 2024 | 155,843.77 |
| Dec 31, 2023 | 168,208.64 |
| Sep 30, 2023 | 205,130.88 |
| Mar 31, 2023 | 315,850.35 |
| Dec 31, 2022 | 370,561.58 |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 1.18 Mn |
| Sep 30, 2021 | 1.81 Mn |
| Jun 30, 2021 | 1.91 Mn |
| Mar 31, 2021 | 1.96 Mn |